To study the possible risk factors for cardiovascular disease, we collected data on plasma levels of coagulation factors, blood pressure, serum cholesterol, and smoking in a random sample of 792 men 54 years of age. During 13.5 years of follow-up, myocardial infarction occurred in 92 men, stroke in 37, and death from causes other than myocardial infarction or stroke in 60. The blood pressure, degree of smoking, serum cholesterol, and fibrinogen level measured at the base-line examination proved to be significant risk factors for infarction by univariate analyses during follow-up, and blood pressure and fibrinogen were risk factors for stroke. Fibrinogen and smoking were strongly related to each other. The relation between fibrinogen and infarction, and between fibrinogen and stroke, became weaker when blood pressure, serum cholesterol, and smoking habits were taken into account, but was still significant for stroke. Although causality cannot be inferred from these data, it is possible that the fibrinogen level plays an important part in the development of stroke and myocardial infarction.
This article has been cited by other articles:
Parastatidis, I., Thomson, L., Burke, A., Chernysh, I., Nagaswami, C., Visser, J., Stamer, S., Liebler, D. C., Koliakos, G., Heijnen, H. F. G., FitzGerald, G. A., Weisel, J. W., Ischiropoulos, H.
(2008). Fibrinogen {beta}-Chain Tyrosine Nitration Is a Prothrombotic Risk Factor. J. Biol. Chem.
283: 33846-33853
[Abstract][Full Text]
Quinn, K., Henriques, M., Parker, T., Slutsky, A. S., Zhang, H.
(2008). Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am. J. Physiol. Heart Circ. Physiol.
295: H1817-H1824
[Abstract][Full Text]
Bhat, V. M., Cole, J. W., Sorkin, J. D., Wozniak, M. A., Malarcher, A. M., Giles, W. H., Stern, B. J., Kittner, S. J.
(2008). Dose-Response Relationship Between Cigarette Smoking and Risk of Ischemic Stroke in Young Women. Stroke
39: 2439-2443
[Abstract][Full Text]
Goetze, J. P.
(2008). Markers of activated coagulation in acute coronary syndromes.. J Am Coll Cardiol
51: 2430-2431
[Full Text]
Wirtz, P. H., Redwine, L. S., Baertschi, C., Spillmann, M., Ehlert, U., von Kanel, R.
(2008). Coagulation Activity Before and After Acute Psychosocial Stress Increases With Age. Psychosom. Med.
70: 476-481
[Abstract][Full Text]
Turin, T. C., Kita, Y., Murakami, Y., Rumana, N., Sugihara, H., Morita, Y., Tomioka, N., Okayama, A., Nakamura, Y., Abbott, R. D., Ueshima, H.
(2008). Higher Stroke Incidence in the Spring Season Regardless of Conventional Risk Factors: Takashima Stroke Registry, Japan, 1988-2001. Stroke
39: 745-752
[Abstract][Full Text]
Packard, R. R. S., Libby, P.
(2008). Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin. Chem.
54: 24-38
[Abstract][Full Text]
Stief, T. W.
(2008). The Fibrinogen Functional Turbidimetric Assay. CLIN APPL THROMB HEMOST
14: 84-96
[Abstract]
Parastatidis, I., Thomson, L., Fries, D. M., Moore, R. E., Tohyama, J., Fu, X., Hazen, S. L., Heijnen, H. F.G., Dennehy, M. K., Liebler, D. C., Rader, D. J., Ischiropoulos, H.
(2007). Increased Protein Nitration Burden in the Atherosclerotic Lesions and Plasma of Apolipoprotein A-I Deficient Mice. Circ. Res.
101: 368-376
[Abstract][Full Text]
Carter, A. M., Catto, A. J., Mansfield, M. W., Bamford, J. M., Grant, P. J.
(2007). Predictive Variables for Mortality After Acute Ischemic Stroke. Stroke
38: 1873-1880
[Abstract][Full Text]
Aono, Y., Ohkubo, T., Kikuya, M., Hara, A., Kondo, T., Obara, T., Metoki, H., Inoue, R., Asayama, K., Shintani, Y., Hashimoto, J., Totsune, K., Hoshi, H., Satoh, H., Izumi, S.-I., Imai, Y.
(2007). Plasma Fibrinogen, Ambulatory Blood Pressure, and Silent Cerebrovascular Lesions: The Ohasama Study. Arterioscler. Thromb. Vasc. Bio.
27: 963-968
[Abstract][Full Text]
Caso, J. R., Pradillo, J. M., Hurtado, O., Lorenzo, P., Moro, M. A., Lizasoain, I.
(2007). Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke. Circulation
115: 1599-1608
[Abstract][Full Text]
Bates, E. R., Babb, C. J. D., Casey, D. E., Cates, C. U., Duckwiler, G. R., Feldman, T. E., Gray, W. A., Ouriel, K., Peterson, E. D., Rosenfield, K., Rundback, J. H., Safian, R. D., Sloan, M. A., White, C. J.
(2007). ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). Vasc Med
12: 35-83
American Society of Interventional & Therapeutic N, , Society for Cardiovascular Angiography and Interve, , Society for Vascular Medicine and Biology, , Society of Interventional Radiology, , Bates, E. R., Babb, J. D., Casey, D. E. Jr, Cates, C. U., Duckwiler, G. R., Feldman, T. E., Gray, W. A., Ouriel, K., Peterson, E. D., Rosenfield, K., Rundback, J. H., Safian, R. D., Sloan, M. A., White, C. J., Harrington, R. A., Abrams, J., Anderson, J. L., Bates, E. R., Eisenberg, M. J., Grines, C. L., Hlatky, M. A., Lichtenberg, R. C., Lindner, J. R., Pohost, G. M., Schofield, R. S., Shubrooks, S. J. JR, Stein, J. H., Tracy, C. M., Vogel, R. A., Wesley, D. J.
(2007). ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol
49: 126-170
[Full Text]
Stief, T. W.
(2007). The Fibrinogen Antigenic Turbidimetric Assay (FIATA): The X2x Test--The Corrected Chi-Square Comparison Against the Control-mean. CLIN APPL THROMB HEMOST
13: 73-100
[Abstract]
Everett, B. M., Kurth, T., Buring, J. E., Ridker, P. M.
(2006). The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. J Am Coll Cardiol
48: 2235-2242
[Abstract][Full Text]
Kiani, A N, Fishman, E K, Petri, M
(2006). Aortic valve calcification in systemic lupus erythematosus. Lupus
15: 873-876
[Abstract]
Sato, S., Iso, H., Noda, H., Kitamura, A., Imano, H., Kiyama, M., Ohira, T., Okada, T., Yao, M., Tanigawa, T., Yamagishi, K., Nakamura, M., Naito, Y., Shimamoto, T.
(2006). Plasma Fibrinogen Concentrations and Risk of Stroke and Its Subtypes Among Japanese Men and Women. Stroke
37: 2488-2492
[Abstract][Full Text]
Hartmann, M., von Birgelen, C., Mintz, G. S., Stoel, M. G., Eggebrecht, H., Wieneke, H., Fahy, M., Neumann, T., van der Palen, J., Louwerenburg, H. W., Verhorst, P. M.J., Erbel, R.
(2006). Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries. J Am Coll Cardiol
48: 446-452
[Abstract][Full Text]
Mora, S., Rifai, N., Buring, J. E., Ridker, P. M
(2006). Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events. Circulation
114: 381-387
[Abstract][Full Text]
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T.
(2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Circulation
113: e409-e449
[Abstract][Full Text]
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T.
(2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Stroke
37: 577-617
[Abstract][Full Text]
van Oijen, M., Witteman, J. C., Hofman, A., Koudstaal, P. J., Breteler, M. M.B.
(2005). Fibrinogen Is Associated With an Increased Risk of Alzheimer Disease and Vascular Dementia. Stroke
36: 2637-2641
[Abstract][Full Text]
Smith, A., Patterson, C., Yarnell, J., Rumley, A., Ben-Shlomo, Y., Lowe, G.
(2005). Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study. Circulation
112: 3080-3087
[Abstract][Full Text]
Fibrinogen Studies Collaboration*,
(2005). Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Meta-analysis. JAMA
294: 1799-1809
[Abstract][Full Text]
Szummer, K. E., Solomon, S. D., Velazquez, E. J., Kilaru, R., McMurray, J., Rouleau, J.-L., Mahaffey, K. W., Maggioni, A. P., Califf, R. M., Pfeffer, M. A., White, H. D., on behalf of the VALIANT registry,
(2005). Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. Eur Heart J
26: 2114-2119
[Abstract][Full Text]
Woodward, M., Lowe, G. D.O., Campbell, D. J., Colman, S., Rumley, A., Chalmers, J., Neal, B. C., Patel, A., Jenkins, A. J., Kemp, B. E., MacMahon, S. W.
(2005). Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke. Stroke
36: 2143-2147
[Abstract][Full Text]
Hermida, R. C., Calvo, C., Ayala, D. E., Lopez, J. E.
(2005). Decrease in Urinary Albumin Excretion Associated With the Normalization of Nocturnal Blood Pressure in Hypertensive Subjects. Hypertension
46: 960-968
[Abstract][Full Text]
Hermida, R. C., Ayala, D. E., Calvo, C., Lopez, J. E., Mojon, A., Fontao, M. J., Soler, R., Fernandez, J. R.
(2005). Effects of Time of Day of Treatment on Ambulatory Blood Pressure Pattern of Patients With Resistant Hypertension. Hypertension
46: 1053-1059
[Abstract][Full Text]
Lind, P., Hedblad, B., Stavenow, L., Engstrom, G., Janzon, L., Ogren, M., Lindgarde, F.
(2005). Incidence of Myocardial Infarction and Death in Relation to Walking-Induced Calf Pain and Plasma Levels of Inflammation-Sensitive Proteins. ANGIOLOGY
56: 507-516
[Abstract]
Sabeti, S., Exner, M., Mlekusch, W., Amighi, J., Quehenberger, P., Rumpold, H., Maurer, G., Minar, E., Wagner, O., Schillinger, M.
(2005). Prognostic Impact of Fibrinogen in Carotid Atherosclerosis: Nonspecific Indicator of Inflammation or Independent Predictor of Disease Progression?. Stroke
36: 1400-1404
[Abstract][Full Text]
Yamamoto, K., Takeshita, K., Kojima, T., Takamatsu, J., Saito, H.
(2005). Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res
66: 276-285
[Abstract][Full Text]
Hansson, G. K.
(2005). Inflammation, Atherosclerosis, and Coronary Artery Disease. NEJM
352: 1685-1695
[Full Text]
van Goor, M P J, Gomez-Garcia, E B, Leebeek, F W G, Brouwers, G J, Koudstaal, P J, Dippel, D W J
(2005). The - 148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study. J. Neurol. Neurosurg. Psychiatry
76: 121-123
[Abstract][Full Text]
Shah, S U, White, A, White, S, Littler, W A
(2004). Heart and mind: (1) relationship between cardiovascular and psychiatric conditions. Postgrad. Med. J.
80: 683-689
[Abstract][Full Text]
Kaditis, A.G., Alexopoulos, E.I., Kalampouka, E., Kostadima, E., Angelopoulos, N., Germenis, A., Zintzaras, E., Gourgoulianis, K.
(2004). Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J
24: 790-797
[Abstract][Full Text]
Link, K., Moell, C., Garwicz, S., Cavallin-Stahl, E., Bjork, J., Thilen, U., Ahren, B., Erfurth, E. M.
(2004). Growth Hormone Deficiency Predicts Cardiovascular Risk in Young Adults Treated for Acute Lymphoblastic Leukemia in Childhood. J. Clin. Endocrinol. Metab.
89: 5003-5012
[Abstract][Full Text]
Rothwell, P. M., Howard, S. C., Power, D. A., Gutnikov, S. A., Algra, A., van Gijn, J., Clark, T. G., Murphy, M. F.G., Warlow, C. P., for the Cerebrovascular Cohort Studies Collaborati,
(2004). Fibrinogen Concentration and Risk of Ischemic Stroke and Acute Coronary Events in 5113 Patients With Transient Ischemic Attack and Minor Ischemic Stroke. Stroke
35: 2300-2305
[Abstract][Full Text]
Gupta, R., Gurm, H., Bartholomew, J. R.
(2004). Smokeless Tobacco and Cardiovascular Risk. Arch Intern Med
164: 1845-1849
[Abstract][Full Text]
Ridker, P. M, Brown, N. J., Vaughan, D. E., Harrison, D. G., Mehta, J. L.
(2004). Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events. Circulation
109: IV-6-IV-19
[Full Text]
Mannami, T., Iso, H., Baba, S., Sasaki, S., Okada, K., Konishi, M., Tsugane, S., for the Japan Public Health Center-Based Prospecti,
(2004). Cigarette Smoking and Risk of Stroke and its Subtypes Among Middle-Aged Japanese Men and Women: The JPHC Study Cohort I. Stroke
35: 1248-1253
[Abstract][Full Text]
Vadseth, C., Souza, J. M., Thomson, L., Seagraves, A., Nagaswami, C., Scheiner, T., Torbet, J., Vilaire, G., Bennett, J. S., Murciano, J.-C., Muzykantov, V., Penn, M. S., Hazen, S. L., Weisel, J. W., Ischiropoulos, H.
(2004). Pro-thrombotic State Induced by Post-translational Modification of Fibrinogen by Reactive Nitrogen Species. J. Biol. Chem.
279: 8820-8826
[Abstract][Full Text]
Ruiz-Bailen, M., de Hoyos, E. A., Reina-Toral, A., Torres-Ruiz, J. M., Alvarez-Bueno, M., Gomez Jimenez, F. J.
(2004). Paradoxical Effect of Smoking in the Spanish Population With Acute Myocardial Infarction or Unstable Angina: Results of the ARIAM Register. Chest
125: 831-840
[Abstract][Full Text]
Lindsberg, P. J., Grau, A. J.
(2003). Inflammation and Infections as Risk Factors for Ischemic Stroke. Stroke
34: 2518-2532
[Abstract][Full Text]
Hermida, R. C., Calvo, C., Ayala, D. E., Lopez, J. E., Fernandez, J. R., Mojon, A., Dominguez, M. J., Covelo, M.
(2003). Seasonal Variation of Fibrinogen in Dipper and Nondipper Hypertensive Patients. Circulation
108: 1101-1106
[Abstract][Full Text]
Tracy, R. P.
(2003). Thrombin, Inflammation, and Cardiovascular Disease: An Epidemiologic Perspective. Chest
124: 49S-57S
[Abstract][Full Text]
Reinhart, W. H
(2003). Fibrinogen - marker or mediator of vascular disease?. Vasc Med
8: 211-216
[Abstract]
De Pablo, P., Ramirez, A., Cortina, E., Pena, A. D. l., Zamora, J., Izaguirre, R., Amigo, M.-C.
(2003). Increased Fibrin Polymerization Rate in Patients with Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus. CLIN APPL THROMB HEMOST
9: 221-225
[Abstract]
Barazzoni, R., Kiwanuka, E., Zanetti, M., Cristini, M., Vettore, M., Tessari, P.
(2003). Insulin Acutely Increases Fibrinogen Production in Individuals With Type 2 Diabetes but Not in Individuals Without Diabetes. Diabetes
52: 1851-1856
[Abstract][Full Text]
Smith, J. C., Lane, H. A., Lewis, J., Dann, S., Goodfellow, J., Collins, P., Evans, L. M., Scanlon, M. F., Davies, J. S.
(2003). Endothelial Function and Coagulant Factors in Growth Hormone-Treated Hypopituitary Adults Receiving Desmopressin. J. Clin. Endocrinol. Metab.
88: 2152-2156
[Abstract][Full Text]
Wang, Y., Levi, C. R., Attia, J. R., D'Este, C. A., Spratt, N., Fisher, J.
(2003). Seasonal Variation in Stroke in the Hunter Region, Australia: A 5-Year Hospital-Based Study, 1995-2000. Stroke
34: 1144-1150
[Abstract][Full Text]
Wolberg, A. S., Monroe, D. M., Roberts, H. R., Hoffman, M.
(2003). Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood
101: 3008-3013
[Abstract][Full Text]
Bowbrick, V. A., Mikhailidis, D. P., Stansby, G.
(2003). Value of Thromboelastography in the Assessment of Platelet Function. CLIN APPL THROMB HEMOST
9: 137-142
[Abstract]
Martiskainen, M., Pohjasvaara, T., Mikkelsson, J., Mantyla, R., Kunnas, T., Laippala, P., Ilveskoski, E., Kaste, M., Karhunen, P.J., Erkinjuntti, T.
(2003). Fibrinogen Gene Promoter -455 A Allele as a Risk Factor for Lacunar Stroke. Stroke
34: 886-891
[Abstract][Full Text]
Fadl, Y. Y., Zareba, W., Moss, A. J., Marder, V. J., Sparks, C. S., Miller Watelet, L. F., Carroll, E. R.
(2003). History of Hypertension and Enhanced Thrombogenic Activity in Postinfarction Patients. Hypertension
41: 943-949
[Abstract][Full Text]
Eidelman, R. S, Hennekens, C. H
(2003). Fibrinogen: a predictor of stroke and marker of atherosclerosis. Eur Heart J
24: 499-500
[Full Text]
Kofoed, S.C., Wittrup, H.H., Sillesen, H., Nordestgaard, B.G.
(2003). Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study. Eur Heart J
24: 567-576
[Abstract][Full Text]
Muir, K. W.
(2002). Inflammation, Blood Pressure, and Stroke: An Opportunity to Target Primary Prevention?. Stroke
33: 2732-2733
[Full Text]
Engstrom, G., Lind, P., Hedblad, B., Stavenow, L., Janzon, L., Lindgarde, F.
(2002). Long-Term Effects of Inflammation-Sensitive Plasma Proteins and Systolic Blood Pressure on Incidence of Stroke. Stroke
33: 2744-2749
[Abstract][Full Text]
Ruberg, F. L, Loscalzo, J.
(2002). Prothrombotic determinants of coronary atherothrombosis. Vasc Med
7: 289-299
[Abstract]
Marquardt, L., Ruf, A., Mansmann, U., Winter, R., Schuler, M., Buggle, F., Mayer, H., Grau, A. J.
(2002). Course of Platelet Activation Markers After Ischemic Stroke. Stroke
33: 2570-2574
[Abstract][Full Text]
Wang, T. J., Nam, B.-H., Wilson, P. W.F., Wolf, P. A., Levy, D., Polak, J. F., D'Agostino, R. B., O'Donnell, C. J.
(2002). Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study. Arterioscler. Thromb. Vasc. Bio.
22: 1662-1667
[Abstract][Full Text]
Kain, K., Catto, A. J
(2002). Insulin resistance syndrome in South Asians. British Journal of Diabetes & Vascular Disease
2: 398-402
[Abstract]
Tanne, D., Haim, M., Boyko, V., Goldbourt, U., Reshef, T., Matetzky, S., Adler, Y., Mekori, Y. A., Behar, S.
(2002). Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke: A Nested Case-Control Study From the Bezafibrate Infarction Prevention (BIP) Study Cohort. Stroke
33: 2182-2186
[Abstract][Full Text]
Mills, J.D., Mansfield, M.W., Grant, P.J.
(2002). Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease. Eur Heart J
23: 1276-1281
[Abstract]
Komarov, A.L., Panchenko, E.P., Dobrovolsky, A.B., Karpov, Yu.A., Deev, A.D., Titaeva, E.V., Davletov, K.K., Eshkeeva, A.R., Markova, L.A.
(2002). D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease. Eur Heart J
23: 1309-1316
[Abstract]
Ridker, P. M.
(2002). Inflammatory Biomarkers, Statins, and the Risk of Stroke: Cracking a Clinical Conundrum. Circulation
105: 2583-2585
[Full Text]
Engstrom, G., Lind, P., Hedblad, B., Stavenow, L., Janzon, L., Lindgarde, F.
(2002). Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men. Circulation
105: 2632-2637
[Abstract][Full Text]
Bots, M L, Elwood, P C, Salonen, J T, Freire de Concalves, A, Sivenius, J, Di Carlo, A, Nikitin, Y, Benetou, V, Tuomilehto, J, Koudstaal, P J, Grobbee, D E
(2002). Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J. Epidemiol. Community Health
56: i14-18
[Abstract][Full Text]
Moons, K G M, Bots, M L, Salonen, J T, Elwood, P C, Freire de Concalves, A, Nikitin, Y, Sivenius, J, Inzitari, D, Benetou, V, Tuomilehto, J, Koudstaal, P J, Grobbee, D E
(2002). Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?. J. Epidemiol. Community Health
56: i30-36
[Abstract][Full Text]
Blake, G.J., Schmitz, C., Lindpaintner, K., Ridker, P.M.
(2001). Mutation in the promoter region of the {beta}-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J
22: 2262-2266
[Abstract]
Palmieri, V., Celentano, A., Roman, M. J., de Simone, G., Lewis, M. R., Best, L., Lee, E. T., Robbins, D. C., Howard, B. V., Devereux, R. B.
(2001). Fibrinogen and Preclinical Echocardiographic Target Organ Damage: The Strong Heart Study. Hypertension
38: 1068-1074
[Abstract][Full Text]
Iacoviello, L., Vischetti, M., Zito, F., Benedetta Donati, M.
(2001). Genes Encoding Fibrinogen and Cardiovascular Risk. Hypertension
38: 1199-1203
[Abstract][Full Text]
Landin-Wilhelmsen, K., Bryman, I., Wilhelmsen, L.
(2001). Cardiac Malformations and Hypertension, But Not Metabolic Risk Factors, Are Common in Turner Syndrome. J. Clin. Endocrinol. Metab.
86: 4166-4170
[Abstract][Full Text]
Liu, Y, Saha, N, Heng, C K, Hong, S, Low, P S
(2001). Fibrinogen genotypes ({alpha} and {beta}) are associated with plasma fibrinogen levels in Chinese. J. Med. Genet.
38: e31-31
[Full Text]
Catto, A. J.
(2001). Genetic aspects of the hemostatic system in cerebrovascular disease. Neurology
57: S24-30
[Abstract][Full Text]
Sramek, A., Reiber, J.H.C., Gerrits, W.B.J., Rosendaal, F.R.
(2001). Decreased Coagulability Has No Clinically Relevant Effect on Atherogenesis: Observations in Individuals With a Hereditary Bleeding Tendency. Circulation
104: 762-767
[Abstract][Full Text]
Mohsenin, V., Culebras, A.
(2001). Sleep-Related Breathing Disorders and Risk of Stroke Editorial Comment : Balancing Sleep and Breathing. Stroke
32: 1271-1278
[Abstract][Full Text]
Williams, M. S., Bray, P. F.
(2001). Genetics of Arterial Prothrombotic Risk States. Exp. Biol. Med.
226: 409-419
[Abstract][Full Text]
Kain, K., Catto, A. J., Young, J., Bamford, J., Bavington, J., Grant, P. J.
(2001). Insulin Resistance and Elevated Levels of Tissue Plasminogen Activator in First-Degree Relatives of South Asian Patients With Ischemic Cerebrovascular Disease. Stroke
32: 1069-1073
[Abstract][Full Text]
Folsom, A. R., Aleksic, N., Park, E., Salomaa, V., Juneja, H., Wu, K. K.
(2001). Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease : The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Bio.
21: 611-617
[Abstract][Full Text]
Lind, P., Hedblad, B., Stavenow, L., Janzon, L., Eriksson, K. F., Lindgarde, F.
(2001). Influence of Plasma Fibrinogen Levels on the Incidence of Myocardial Infarction and Death Is Modified by Other Inflammation-Sensitive Proteins : A Long-Term Cohort Study. Arterioscler. Thromb. Vasc. Bio.
21: 452-458
[Abstract][Full Text]
Iso, H., Rexrode, K. M., Stampfer, M. J., Manson, J. E., Colditz, G. A., Speizer, F. E., Hennekens, C. H., Willett, W. C.
(2001). Intake of Fish and Omega-3 Fatty Acids and Risk of Stroke in Women. JAMA
285: 304-312
[Abstract][Full Text]
Eitzman, D. T., Westrick, R. J., Xu, Z., Tyson, J., Ginsburg, D.
(2000). Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood
96: 4212-4215
[Abstract][Full Text]
Sykes, T C F, Fegan, C, Mosquera, D
(2000). Thrombophilia, polymorphisms, and vascular disease. Mol. Pathol.
53: 300-306
[Abstract][Full Text]
WESSENDORF, T. E., THILMANN, A. F., WANG, Y.-M., SCHREIBER, A., KONIETZKO, N., TESCHLER, H.
(2000). Fibrinogen Levels and Obstructive Sleep Apnea in Ischemic Stroke. Am. J. Respir. Crit. Care Med.
162: 2039-2042
[Abstract][Full Text]
Sechi, L. A., Zingaro, L., Catena, C., Casaccio, D., De Marchi, S.
(2000). Relationship of Fibrinogen Levels and Hemostatic Abnormalities With Organ Damage in Hypertension. Hypertension
36: 978-985
[Abstract][Full Text]
Crawford, V.L.S., Sweeney, O., Coyle, P.V., Halliday, I.M., Stout, R.W.
(2000). The relationship between elevated fibrinogen and markers of infection: a comparison of seasonal cycles. QJM
93: 745-750
[Abstract][Full Text]
Pieper, C. F., Rao, K. M. K., Currie, M. S., Harris, T. B., Cohen, H. J.
(2000). Age, Functional Status, and Racial Differences in Plasma D-Dimer Levels in Community-Dwelling Elderly Persons. J. Gerontol. A Biol. Sci. Med. Sci.
55: 649M-657
[Abstract][Full Text]
Woods, A., Brull, D.J., Humphries, S.E., Montgomery, H.E.
(2000). Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J
21: 1574-1583
Tegos, T. J., Kalodiki, E., Daskalopoulou, S.-S., Nicolaides, A. N.
(2000). Stroke: Epidemiology, Clinical Picture, and Risk Factors: Part I of III. ANGIOLOGY
51: 793-808
[Abstract]
Van de Water, N. S., French, J. K., Lund, M., Hyde, T. A., White, H. D., Browett, P. J.
(2000). Prevalence of factor v leiden and prothrombin variant g20210a in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol
36: 717-722
[Abstract][Full Text]
Barazzoni, R., Zanetti, M., Davanzo, G., Kiwanuka, E., Carraro, P., Tiengo, A., Tessari, P.
(2000). Increased Fibrinogen Production in Type 2 Diabetic Patients without Detectable Vascular Complications: Correlation with Plasma Glucagon Concentrations. J. Clin. Endocrinol. Metab.
85: 3121-3125
[Abstract][Full Text]
Sato, S., Nakamura, M., Iida, M., Naito, Y., Kitamura, A., Okamura, T., Nakagawa, Y., Imano, H., Kiyama, M., Iso, H., Shimamoto, T., Komachi, Y.
(2000). Plasma Fibrinogen and Coronary Heart Disease in Urban Japanese. Am J Epidemiol
152: 420-423
[Abstract][Full Text]
Cusack, M., Redwood, S., Coltart, J.
(2000). Recent advances in ischaemic heart disease. Postgrad. Med. J.
76: 542-546
[Full Text]
Isasi, C. R., Starc, T. J., Tracy, R. P., Deckelbaum, R., Berglund, L., Shea, S.
(2000). Inverse Association of Physical Fitness with Plasma Fibrinogen Level in Children The Columbia University BioMarkers Study. Am J Epidemiol
152: 212-218
[Abstract][Full Text]
Previous
